Follow
International Journal of Current Microbiology and Applied Sciences (IJCMAS)
IJCMAS is now DOI (CrossRef) registered Research Journal. The DOIs are assigned to all published IJCMAS Articles.
Index Copernicus ICI Journals Master List 2018 - IJCMAS--ICV 2018: 95.39 For more details click here
National Academy of Agricultural Sciences (NAAS) : NAAS Score: *5.38 (2020) [Effective from January 1, 2020]For more details click here

Login as a Reviewer

Indexed in



National Academy of Agricultural Sciences (NAAS)
NAAS Score: *5.38 (2020)
[Effective from January 1, 2020]
For more details click here

ICV 2018: 95.39
Index Copernicus ICI Journals Master List 2018 - IJCMAS--ICV 2018: 95.39
For more details click here

See Guidelines to Authors
Current Issues

Original Research Articles

PRINT ISSN : 2319-7692
Online ISSN : 2319-7706
Issues : 12 per year
Publisher : Excellent Publishers
Email : editorijcmas@gmail.com / submit@ijcmas.com
Editor-in-chief: Dr.M.Prakash
Index Copernicus ICV 2018: 95.39
NAAS RATING 2020: 5.38

Int.J.Curr.Microbiol.App.Sci.2018.7(2): 120-125
DOI: https://doi.org/10.20546/ijcmas.2018.702.015


Co-trimoxazole Resistance in Clinical Isolates of Stenotrophomonas maltophilia
Neha Shah1*, S. Basireddy2, Sreeja Vamsi2 and Vasanti Kabra2
1Department of Microbiology, Smth Kashibai Navale Medical College and General Hospital, Pune, India
2Department of Microbiology, SVS Medical College, Mehboobnagar, A.P., India
*Corresponding author
Abstract:

Stenotrophomonas maltophilia is increasingly being isolated as a nosocomial pathogen. It is the third most common non-fermenting gram negative bacilli (NFGNB) isolated from the clinical samples especially from the respiratory specimens, blood, urine and pus samples. Though inherently resistant to many groups of antibiotics, its susceptibility to co-trimoxazole is a peculiar character, because of which Co-trimoxazole is considered as the drug of choice for treating these infections. Recently there has been an increase in the incidence of resistance against Co-trimoxazole with variable resistance towards other antibiotics. In the present study 14.2% of the isolates were resistant to Co-trimoxazole. Resistant to other antibiotics was also very high. Ciprofloxacin and Chloramphenicol have shown reasonably good activity against this organism making these drugs as therapeutic alternatives in Co-trimoxazole resistant cases


Keywords: Stenotrophomonas maltophilia, Co-trimoxazole, NFGNB, Drug resistance
Download this article as Download

How to cite this article:

Neha Shah, S. Basireddy, Sreeja Vamsi and Vasanti Kabra. 2018. Co-trimoxazole Resistance in Clinical Isolates of Stenotrophomonas maltophilia.Int.J.Curr.Microbiol.App.Sci. 7(2): 120-125. doi: https://doi.org/10.20546/ijcmas.2018.702.015